Global EditionASIA 中文双语Français
Home / China / Innovation

Chinese scientists design cocktail antibody to treat, prevent COVID-19

Xinhua | Updated: 2022-03-02 13:50
Share - WeChat

BEIJING -- Chinese scientists designed a cocktail antibody that can deliver a one-two punch to the coronavirus that causes COVID-19.

The researchers from Capital Medical University and Chinese Academy of Sciences developed the bispecific human monoclonal antibody against SARS-CoV-2, combining a noncompeting pair of human neutralizing antibodies, namely B38 and H4, to target two antigens, thus blocking the virus from binding to its receptor.

The double-kill antibody or bsAb15 has shown greater neutralizing efficiency than its parental ones, and more potent neutralizing activity against the Delta variant, according to the study published on Nature Immunology this week.

They selected escape mutants of the two parental antibodies and demonstrated that bsAb15 can efficiently neutralize all escape mutants of single antibodies.

Also, the new antibody was shown to reduce the viral titer in infected nonhuman primates and human ACE2 transgenic mice, making it a feasible and effective potential strategy to treat and prevent severe COVID-19, according to the study.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349